BioNTech vaccine: Available in Germany from October for children 5-11 years old

The vaccine will be available for children aged 5-11 from mid-October BioNTech against Covid-19 in Germany, the company itself estimates, according to statements by its co-founder, Ezlem Touretzi in Der Spiegel magazine. She also warns that we have two months to avoid a difficult winter. “Blessing for the world,” said Health Minister Jens Spann.

“In the coming weeks we will present to the authorities worldwide the results of our study for children aged 5-11 and we will apply for the approval of the vaccine for this age group – and here in Europe. We are already preparing the production. The vaccine will be the same, but at a lower dose “, clarifies Ms. Touretsi and states that the studies are already ready and must now be taken into consideration by the competent authorities. “Everything looks okay, everything is going according to plan,” he notes. while it does not rule out that by the end of the year studies for infants from six months will be available.

Touretsi also called on citizens to rush to get vaccinated in the face of winter, stressing that “we as a society still have 60 days to prevent a difficult winter” and we must do everything possible to mobilize as many people as possible. “Every extra vaccine helps. “We must not give up,” he said.

“This is good news. Its approval vaccine will facilitate better protection of children. “The vaccine made in Germany is a blessing to the world,” Health Minister Jens Spann told the RND network, according to the APE-MPE correspondent in Berlin.

According to the same network, some countries are already vaccinating under-12s. The Chinese Coronavac vaccine will be given to children over the age of six in Chile next week.